Multiple Choice
Patients who have a poor metabolism phenotype will have:
A) Slowed metabolism of a prodrug into an active drug, leading to accumulation of prodrug
B) Accumulation of inactive metabolites of drugs
C) A need for increased dosages of medications
D) Increased elimination of an active drug
Correct Answer:

Verified
Correct Answer:
Verified
Q2: Ultra-rapid metabolizers of drugs may have:<br>A) To
Q3: Genetic polymorphisms account for differences in metabolism,
Q4: Carbamazepine has a Black Box Warning recommending
Q5: Warfarin resistance may be seen in patients
Q6: A provider may consider testing for CYP2D6
Q8: Rifampin is a nonspecific CYP450 inducer that
Q9: Up to 21% of Asians are ultra-rapid
Q10: Inhibition of P-glycoprotein by a drug such
Q11: Pharmacogenetic testing is required by the U.S.
Q12: Genetic testing for VCORC1 mutation to assess